MedTrace Logo

Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

NCT03447886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2021-06-11

No results posted yet for this study

Summary

The overall goal of this study is to qualitatively explore how behavioral, cultural, psychosocial, and economic barriers and facilitators affect the decision to start and adhere to endocrine therapy (ET) among young breast cancer survivors of diverse racial, ethnic, and socio-economic backgrounds with hormone receptor positive (HR+) breast cancer

Conditions

Interventions

OTHER

Phone interview

Collecting clinical and socio-demographic information.

Sponsors & Collaborators

Principal Investigators

  • Rachel A Freedman, MD, MPH · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2018-08-27
Completion
2018-08-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447886 on ClinicalTrials.gov